These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22197672)

  • 1. Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.
    Yuki H; Honma T; Hata M; Hoshino T
    Bioorg Med Chem; 2012 Jan; 20(2):775-83. PubMed ID: 22197672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
    Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
    Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
    Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based site of metabolism prediction for cytochrome P450 2D6.
    Moors SL; Vos AM; Cummings MD; Van Vlijmen H; Ceulemans A
    J Med Chem; 2011 Sep; 54(17):6098-105. PubMed ID: 21797232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
    Kang P; Liao M; Wester MR; Leeder JS; Pearce RE; Correia MA
    Drug Metab Dispos; 2008 Mar; 36(3):490-9. PubMed ID: 18096676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
    Denisov IG; Grinkova YV; Baylon JL; Tajkhorshid E; Sligar SG
    Biochemistry; 2015 Apr; 54(13):2227-39. PubMed ID: 25777547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
    Kirton SB; Murray CW; Verdonk ML; Taylor RD
    Proteins; 2005 Mar; 58(4):836-44. PubMed ID: 15651036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of cytochrome P450 xenobiotic metabolism: tethered docking and reactivity derived from ligand molecular orbital analysis.
    Tyzack JD; Williamson MJ; Torella R; Glen RC
    J Chem Inf Model; 2013 Jun; 53(6):1294-305. PubMed ID: 23701380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of protein flexibility on the site of metabolism prediction for CYP2A6 substrates.
    Sheng Y; Chen Y; Wang L; Liu G; Li W; Tang Y
    J Mol Graph Model; 2014 Nov; 54():90-9. PubMed ID: 25459760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Prediction of the Site(s) of Metabolism and Binding Modes of Protein Kinase Inhibitors Metabolized by CYP3A4.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Dispos; 2019 Jun; 47(6):616-631. PubMed ID: 30902802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.
    Denisov IG; Grinkova YV; Nandigrami P; Shekhar M; Tajkhorshid E; Sligar SG
    Biochemistry; 2019 Mar; 58(10):1411-1422. PubMed ID: 30785734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regiospecificity of human cytochrome P450 1A1-mediated oxidations: the role of steric effects.
    Ericksen SS; Szklarz GD
    J Biomol Struct Dyn; 2005 Dec; 23(3):243-56. PubMed ID: 16218752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MD Investigation on the Interaction between Carbamazepine and Two CYP Isoforms, CYP3A4 and CYP3A5.
    Liu S; Xu Y
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
    Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
    Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynamics and Inhibitor Discovery.
    Du H; Li J; Cai Y; Zhang H; Liu G; Tang Y; Li W
    J Chem Inf Model; 2017 Mar; 57(3):616-626. PubMed ID: 28221037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation.
    Keizers PH; de Graaf C; de Kanter FJ; Oostenbrink C; Feenstra KA; Commandeur JN; Vermeulen NP
    J Med Chem; 2005 Sep; 48(19):6117-27. PubMed ID: 16162012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding free energies of inhibitors to iron porphyrin complex as a model for Cytochrome P450.
    Lee JY; Kang NS; Kang YK
    Biopolymers; 2012 Apr; 97(4):219-28. PubMed ID: 22113809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen.
    Shahrokh K; Cheatham TE; Yost GS
    Biochim Biophys Acta; 2012 Oct; 1820(10):1605-17. PubMed ID: 22677141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of protein flexibility and active site water molecules on the prediction of sites of metabolism for cytochrome P450 2C19 substrates.
    Li J; Cai J; Su H; Du H; Zhang J; Ding S; Liu G; Tang Y; Li W
    Mol Biosyst; 2016 Mar; 12(3):868-78. PubMed ID: 26761525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the binding modes and sites of metabolism of xenobiotics.
    Mukherjee G; Lal Gupta P; Jayaram B
    Mol Biosyst; 2015 Jul; 11(7):1914-24. PubMed ID: 25913019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.